Trademark: 88637695
Status Date
Monday, December 14, 2020
Filing Date
Tuesday, October 1, 2019
Abandoned Date
Monday, November 9, 2020
44 Genomic and molecular medical testing for cancer and other diagnostic or treatment purposes provided to healthcare professionals through a software platform; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders provided to healthcare professionals through a software platform; providing collected and analyzed medical information to health care professionals through a software platform in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals through a software platform; molecular medical testing offered to health care professionals for cancer using artificial intelligence and machine learning capabilities to identify unique molecular signatures
Dec 14, 2020
Abandonment Notice E-Mailed - Express Abandonment
Dec 14, 2020
Abandonment - Express Mailed
Nov 9, 2020
Teas Request For Reconsideration Received
Jun 1, 2020
Notification Of Final Refusal Emailed
Jun 1, 2020
Final Refusal E-Mailed
Jun 1, 2020
Final Refusal Written
May 6, 2020
Teas/Email Correspondence Entered
May 6, 2020
Correspondence Received In Law Office
May 6, 2020
Teas Response To Office Action Received
Nov 6, 2019
Notification Of Non-Final Action E-Mailed
Nov 6, 2019
Non-Final Action E-Mailed
Nov 6, 2019
Non-Final Action Written
Nov 6, 2019
Assigned To Examiner
Oct 4, 2019
New Application Office Supplied Data Entered In Tram
Oct 4, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
